top of page

Search


A Look Ahead: Specialty Therapies Shaping Tomorrow
Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined Prime Therapeutics' Specialty Summit.
Sep 22


Pipeline Pulse 2026: Emerging Therapies and Trends Impacting Managed Care Pharmacy
Andrew Levitsky, PharmD, BCPS, and Irvin Molina, PharmD, BCOP, BCPS, CSP, joined the AMCP Florida-Puerto Rico Day of Education.
Sep 19


Emerging Therapies in the Medication Pipeline Landscape
Marina Sehman, PharmD, CSP, Director of Clinical Pharmacy at IPD Analytics, joined the AMCP California Day of Education.
Sep 19


A Data Led Review of Settlement Strategy and Outcomes in Pharma Patent Disputes
Charles Haisch and Scott Allen presented at the Pharma and Biotech Patent Litigation Summit North America.
Sep 15


Medicare Part D Redesign Reshapes Market
Part D enrollment has shifted: standalone plan offerings are down 22%, while special needs plans grew 21%, reshaping competition among fewer, larger sponsors nationally, finds an analysis by IPD Analytics.
Sep 8


Emerging Topics in Medicaid: A Managed Care Pharmacy Perspective
Bethany Holderread, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education.
Aug 28


Precision Oncology: Diagnostics, Biomarker-Driven Therapies and Payer Considerations
Jennifer Billings, Senior Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education (DOE).
Aug 28


Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Alyssa Guest, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)."
Aug 14


Cell and Gene Therapy, and New Drug Update
Bethany Holderread will present two sessions at the 2026 AMPAA Annual Conference.
Aug 3


Coming Attractions: What's New in Cell and Gene Therapy
Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the 2026 Texas Pharmacy Association Conference & Expo.
Jul 26


The LOE cliff
Some of the most widely prescribed and profit‑generating biologic therapies are set to lose exclusivity over the next few years, yet only a fraction have a biosimilar competitor currently in development.
Jul 13


Trends in Commercial Payer Coverage of Accelerated Approval Therapies
Sheetal Sheth, PharmD, BCOP, presented "Rends in Commercial Payer Coverage of Accelerated Approval Therapies" poster on behalf of her co-authors Michelle Rogers, PharmD, BCPS, and Irvin Molina, PharmD, BCOP, BCPS, CSP, at Oncology Pharmacists Connect 2026.
Jun 18


Most Favored Nation: A Closer Look Below the Surface
Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Most Favored Nation: A Closer Look Below the Surface" at the Mississippi Association of Health Plans Annual Conference.
Jun 2


Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction
Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined the AMCP Northeast Evening of Education panel on May 14, 2026.
May 14


Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Kimberly Grant, Director of Clinical Pharmacy at IPD Analytics, presented at AMCP Northwest Day of Education.
May 14


Institute for Clinical and Economic Review Publishes Protocol for Annual Launch Price and Access Report
By FirstWord Pharma | Original Article BOSTON, May 4, 2026 - The Institute for Clinical and Economic Review (ICER) posted a Protocol today outlining how it will conduct its second annual analysis titled the “Launch Price and Access Report,” which will examine launch prices and patient access for new FDA-approved treatments. This protocol was developed with input from a multi-stakeholder working group* consisting of patient and consumer advocates, clinicians, policy experts, p
May 6


Pharmaceutical Pipeline Update: What Employers Need to Know
Jeffrey Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy, and Julie Kendle, PharmD, Senior Director of Clinical Pharmacy at IPD Analytics, presented "Pharmaceutical Pipeline Update: What Employers Need to Know" at the Employers Health webinar.
Apr 28


The Three Areas of a Patient's PrEP Journey Where Managed Care Organizations can be Beneficial | AMCP Annual 2026
Julie Kendle, Pharm.D., Senior Director of Clinical Pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.
Apr 20


What Managed Care Organizations Should Be Paying Attention To If They Want To Improve PrEP Access | AMCP Annual 2026
Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.
Apr 16


A Look at Past and Present HIV Prevention Therapies | AMCP Annual 2026
Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.
Apr 16


Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars
Andrew Levitsky, PharmD, BCPS, and Marina Sehman, PharmD, CSP, at IPD Analytics presented, "Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars" at the AMCP Annual Meeting 2026.
Apr 15


Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
Julie Kendle, PharmD at IPD Analytics and Kelsea Aragon, PharmD, PhC, BCACP, CDCES, AAHIVP, at the UNM College of Pharmacy, presented, "Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care" at the AMCP Annual Meeting 2026.
Apr 14


The Impact of Expanded Indications for Glucagon-Like Peptide-1 Receptor Agonist-Based Anti-Obesity Medications in State Medicaid Fee-For-Service Pharmacy Programs
Alyssa Guest, PharmD, Stephanie Tran, PharmD, MPH, BCPS, and Bethany Holderread, PharmD, presented their award-winning poster, "The Impact of Expanded Indications for Glucagon-Like Peptide 1 Receptor Agonist-Based Anti-Obesity Medications in State Medicaid Fee-For-Service Pharmacy Programs," at the AMCP Annual Meeting 2026 in Nashville, TN.
Apr 14


The Future of Pharmacy: What the MHE 2026 Pharmacy Survey Signals for the Year Ahead
Managed Healthcare Executive conducted its annual pharmacy survey, capturing perspectives from payers, pharmacy leaders, health systems, academic institutions, government and pharmacy benefit managers (PBMs).
Apr 13
bottom of page
